DPYD Genetic Test Expanded to Include African Ancestry Variant
England's NHS expands pre-chemotherapy DPYD screening to include a variant more common in patients of African ancestry, reducing cancer care inequalities.
Oncology
The latest oncology coverage from Hawaii Medical Journal.
FDA Rejects Replimune Skin Cancer Drug Amid Capitol Hill Scrutiny
The FDA rejected Replimune's advanced skin cancer drug, citing flawed trial design. RFK Jr. and Congress clash over the agency's evidentiary standards.
KRAS Inhibitor Daraxonrasib Shows Promise in Pancreatic Cancer
Revolution Medicines' daraxonrasib shows meaningful responses in KRAS-mutant pancreatic cancer in Phase 2 data, marking a breakthrough in a notoriously hard-to-treat disease.
Revolution Medicines Raises $2B After Pancreatic Cancer Trial
Revolution Medicines closed a $2 billion raise after Phase 3 data showed daraxonrasib doubled median overall survival in advanced pancreatic cancer.
Pancreatic Cancer Pill Doubles Survival in New Trial
Revolution Medicines' daraxonrasib nearly doubled median survival in metastatic pancreatic cancer patients compared to chemotherapy, according to new data.
Merck Acquires Terns Pharmaceuticals for $6.7B in 2026
Merck's $6.7B acquisition of Terns Pharmaceuticals targets TERN-701, a leukemia drug that could shore up its oncology pipeline amid patent pressures.
By James Liu